Results of the prospective, randomized, multicenter food and drug administration investigational device exemption study of the ProDisc®-L total disc replacement versus circumferential fusion for the treatment of 1-level degenerative disc disease

Jack Zigler, Rick Delamarter, Jeffrey M. Spivak, Raymond J. Linovitz, Guy O. Danielson, Thomas T. Haider, Frank Cammisa, Jim Zuchermann, Richard Balderston, Scott Kitchel, Kevin Foley, Robert Watkins, David Bradford, James Yue, Hansen Yuan, Harry Herkowitz, Doug Geiger, John Bendo, Timothy Peppers, Barton SachsFederico Girardi, Michael Kropf, Jeff Goldstein

Research output: Contribution to journalArticlepeer-review

371 Scopus citations

Fingerprint

Dive into the research topics of 'Results of the prospective, randomized, multicenter food and drug administration investigational device exemption study of the ProDisc®-L total disc replacement versus circumferential fusion for the treatment of 1-level degenerative disc disease'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science